Patients with kidney disease are at increased risk for a range of respiratory complications due to the complex interplay between renal dysfunction, fluid imbalance, and systemic inflammation. Respiratory complications in kidney disease commonly include pulmonary edema, pleural effusions, sleep-disordered breathing, and an increased susceptibility to infections such as pneumonia. Impaired renal function can lead to fluid retention, electrolyte disturbances, and acid-base imbalances, all of which can compromise lung mechanics and gas exchange. Effective management requires early recognition of symptoms such as shortness of breath, persistent cough, or hypoxia, alongside careful monitoring of fluid status and cardiovascular function. Interventions may include optimized dialysis protocols, respiratory support, pharmacological management, and targeted rehabilitation to maintain lung capacity and prevent complications. Respiratory complications in kidney disease also highlight the importance of multidisciplinary care, with nephrologists, pulmonologists, critical care specialists, and respiratory therapists collaborating to provide coordinated treatment plans. Preventive strategies, including vaccination, infection control measures, and patient education on symptom recognition, are crucial in reducing morbidity and improving outcomes. Emerging research explores the impact of novel therapies and personalized approaches to mitigate pulmonary risks in patients with chronic kidney disease. By understanding the mechanisms linking renal impairment and respiratory dysfunction, healthcare providers can implement timely interventions, improve quality of life, and reduce hospitalization rates, emphasizing the need for comprehensive, proactive management of respiratory health in this vulnerable patient population.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation